Sarcoidosis: Can a murine model help define a role for silica?

Medical Hypotheses

Volumn 78, Issue 1, 2012, Pages 36-38

  Yeager, Henry ^a   Gopalan, Sindhu ^a   Mathew, Paul ^a   Lawless, Oliver ^a   Bellanti, Joseph A ^a  

^a GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; INFLAMMASOME; SILICON DIOXIDE;

ARTICLE; EXPERIMENTAL MODEL; GASTROINTESTINAL TRACT; GRANULOMA; HUMAN; HYPOTHESIS; LUNG; MYCOBACTERIUM; NONHUMAN; PATHOGENESIS; RISK; SARCOIDOSIS;

ANIMALS; DISEASE MODELS, ANIMAL; MICE; MODELS, BIOLOGICAL; MYCOBACTERIACEAE; SARCOIDOSIS; SILICON DIOXIDE;

ANIMALIA; CORYNEBACTERINEAE; FUNGI; MURINAE;

EID: 83155180366     PISSN: 03069877     EISSN: 15322777     Source Type: Journal    
DOI: 10.1016/j.mehy.2011.09.036     Document Type: Article

References (29)

1. Morgenthau A.S., Iannuzzi M.C. Recent advances in sarcoidosis. Chest 2011, 139(1):174-182.
2. Iannuzzi M.C., Fontana J.R. Sarcoidosis: clinical presentation, immunopathogenesis, and therapeutics. JAMA 2011, 305(4):391-399.
3. Baughman R.P., Culver D.A., Judson M.A. A concise review of pulmonary sarcoidosis. Am J Respir Crit Care Med 2011, 183(5):573-581.
4. Rybicki B.A., Iannuzzi M.C., Frederick M.M., et al. Familial aggregation of sarcoidosis. A case-control etiologic study of sarcoidosis (ACCESS). Am J Respir Crit Care Med 2001, 164:2085-2091.
5. Grunewald J. Review: role of genetics in susceptibility and outcome of sarcoidosis. Semin Respir Crit Care Med 2010, 31(4):380-389.
6. Chapman J.S., Speight M. Further studies of mycobacterial antibodies in the sera of patients with sarcoidosis. Acta Med Scand Suppl 1964, 425:146-148.
7. Chapman J.S., Baum J., Clark J., Speight M. Mycobacterial antibodies in immunoglobulins IgA and IgM of patients with sarcoidosis. Amer Rev Resp Dis 1967, 95:612-617.
8. Ishige I., Usui Y., Takemura T., Eishi Y. Quantitative PCR of mycobacterial and propionibacterial DNA in lymph nodes of Japanese patients with sarcoidosis. Lancet 1999, 354:120-123.
9. Eishi Y., Suga M., Ishige I., et al. Quantitative analysis of mycobacterial and propionibacterial DNA in lymph nodes of Japanese and European patients with sarcoidosis. J Clin Micro 2002, 40(1):198-204.
10. Drake W.P., Pei Z., Pride D.T., et al. Molecular analysis of sarcoidosis tissues for mycobacterium species DNA. Emerg Infect Dis 2002, 8(11):1334-1341.
11. Allen S.S., Evans W., Carlisle J., et al. Superoxide dismutase antigens derived from molecular analysis of sarcoidosis granulomas elicit systemic Th-1 immune responses. Resp Res 2008, 9:36.
12. Oswald-Richter K., Sato H., Hajizadeh R., et al. Mycobacterial ESAT-6 and katG are recognized by sarcoidosis CD4+ T cells when presented by the american sarcoidosis susceptibility allele, DRB1i1101. J Clin Immunol 2010, 30(1):157-166.
13. Oswald-Richter K., Culver D.A., Hawkins C., et al. Cellular responses to mycobacterial antigens are present in bronchoalveolar lavage fluid used in the diagnosis of sarcoidosis. Infect Immun 2009, 77(9):3740-3748.
14. Song Z, Marzilli L, Greenlee BM, et al. Mycobacterial catalase-peroxidase is a tissue antigen and target of the adaptive immune response in systemic sarcoidosis. J Exp Med 2005;201(5):755-67. Erratum in: J Exp Med 2005;202(5):721.
15. Chen E.S., Wahlström J., Song Z., et al. T cell responses to mycobacterial catalase peroxidase profile a pathogenic antigen in systemic sarcoidosis. J Immunol 2008, 181(12):8784-8796.
16. Brownell I, Ramírez-Valle F, Sanchez M, Prystowsky S. Evidence for mycobacteria in sarcoidosis. Am J Respir Cell Mol Biol, 2011 [Epub ahead of print].
17. Terčelj M., Salobir B., Harlander M., Rylander R. Fungal exposure in homes of patients with sarcoidosis - an environmental exposure study. Environ Health 2011, 10(1):8.
18. Park J.H., Cox-Ganser J.M. Mold exposure and respiratory health in damp indoor environments. Front Biosci (Elite Ed) 2011, 3:757-771.
19. Solà R., Boj M., Hernandez-Flix S., Camprubí M. Silica in oral drugs as a possible sarcoidosis-inducing antigen. Lancet 2009, 373(9679):1943-1944.
20. Swaisgood C.M., Oswald-Richter K., Moeller S.D., et al. Development of a sarcoidosis murine lung granuloma model using mycobacterium superoxide dismutase a peptide. Am J Respir Cell Mol Biol 2011, 44(2):166-174.
21. Prezant D.J., Dhala A., Goldstein A., et al. The incidence, prevalence, and severity of sarcoidosis in New York city firefighters. Chest 1999, 116(5):1183-1193.
22. Izbicki G., Chavko R., Banauch G.I., et al. World trade center " sarcoid-like" granulomatous pulmonary disease in New York city fire department rescue workers. Chest 2007, 131(5):1414-1423.
23. Crowley L.E., Herbert R., Moline J.M., et al. " Sarcoid-like" granulomatous pulmonary disease in world trade center disaster responders. Am J Ind Med 2011, 54(3):175-184.
24. Rafnsson V., Ingimarsson O., Hjalmarsson I., Gunnarsdottir H. Association between exposure to crystalline silica and risk of sarcoidosis. Occup Environ Med 1998, 55(10):657-660.
25. Comstock G.W., Keltz H., Sencer D.J. Clay eating and sarcoidosis. A controlled study in the state of Georgia. Am Rev Respir Dis 1961, 84(Part 2):130.
26. Langley R.J., Mishra N.C., Peña-Philippides J.C., Hutt J.A., Sopori M.L. Granuloma formation induced by low-dose chronic silica inhalation is associated with an antiapoptotic response in Lewis rats. J Toxicol Environ Health A 2010, 73(10):669-683.
27. Castranova V., Porter D., Millecchia L., Ma J.Y., Hubbs A.F., Teass A. Effect of inhaled crystalline silica in a rat model: time course of pulmonary reactions. Mol Cell Biochem 2002, 234-235(1-2):177-184.
28. Martinon F., Mayor A., Tschopp J. The inflammasomes: guardians of the body. Ann Rev Immunol 2009, 27:229-265.
29. Hoffman H.M., Brydges S.D. Genetic and molecular basis of inflammasome-mediated disease. J Biol Chem 2011, 286:10889-10896.